Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intervention Study on Psychocardiology by Xinkeshu Tablets
ChiCTR-IPR-17010940Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jan 2017
- Countries
- 1
01
Overview
Phase 4, single-arm trial of xinkeshu in coronary arteriosclerosis, anxiety disorder and major depressive disorder (MDD), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Chest pain severity and frequency, Anxiety severity and 3 more. Started Jan 2017; status: recruiting.
02
Drugs
xinkeshu
03
Conditions
coronary arteriosclerosisanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-IPR-17010940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010940.